From left, Claire Adam of ARUP Laboratories, Jimmy McDonough of the Talent Ready Utah Center, and Michaela Hatch of Recursion discuss how returnships can help ensure that women won’t abandon careers in science, technology, engineering, and math. |
November 2, 2023 |
ARUP Among Companies That Support Returnships for Workforce Reentry During a networking event cohosted by ARUP, leaders in the life sciences advocated for more returnships to help those who have taken time off ease back into careers in STEM. |
October 26, 2023 |
Fall 2023 Edition of ARUP’s Magnify Magazine Now Available Online The newest edition highlights innovations that keep ARUP at the forefront of toxicology testing. Also featured: ARUP’s expanded capacity for cytogenetics testing. |
|
Waseem Anani, MD, medical director of ARUP Blood Services, announced the new Whole Blood Titans program from the University of Utah Hospital helipad on October 18. |
October 19, 2023 | ARUP Blood Services has announced the rollout of its Whole Blood Titan program, which will encourage donations of low-titer, type O blood that is vital to saving lives in emergency situations. |
Dave Shiembob, manager of ARUP Healthcare Advisory Services, guides clients with utilization best practices and real-time opportunities. |
October 10, 2023 |
ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award A platform clients use to reduce testing waste, lower cost per test, and improve patient safety has won the prestigious Choosing Wisely Champion Award from the American Society for Clinical Pathology. |
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new resources in September. |
October 5, 2023 | ARUP Consult, a free source of expert guidance in laboratory testing, has released new resources on testing for polycystic ovary syndrome and autoimmune encephalitis. |
A woman collects a saliva sample, a specimen type validated for the COVID-19 molecular diagnostic test developed during the COVID-19 pandemic as a laboratory-developed test. |
October 2, 2023 | The FDA’s newly proposed rules would regulate all in vitro diagnostic products as medical devices if enacted. ARUP believes additional FDA oversight would disrupt the diagnostic testing market. |